Association Between Obesity and Risk of Total and Obesity-Related Cancer in People With Incident Cardiovascular Disease.

cardiovascular disease cardio‐oncology epidemiology obesity population science

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
27 Aug 2024
Historique:
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: aheadofprint

Résumé

Cardiovascular disease (CVD) and cancer frequently co-occur due to shared risk factors such as obesity, which is linked to CVD and 14 cancer types. This study explores whether CVD pathophysiologies, combined with obesity, increase cancer risk, impacting clinical management. Data from the ARIC (Atherosclerosis Risk in Communities) study, spanning 28 years, were analyzed. The cohort included 5127 participants with incident CVD (myocardial infarction, stroke, heart failure, coronary heart disease), of whom 1511 developed a first primary cancer. Follow-up began at CVD diagnosis after Visit 1. Obesity was assessed using body mass index, waist circumference, and waist-to-hip ratio. Incidence rate differences between obesity groups were adjusted for age, sex, and center, whereas the obesity-cancer association was estimated using Fine-Gray regression adjusted for shared risk factors including smoking. Cancer incidence in obese individuals with CVD (body mass index: rate differences=226.6/100 000 person-years) was higher than in those with normal weight. Although obesity was not linked to overall cancer after adjusting for shared risk factors, it was nominally associated with obesity-related cancers. Specifically, women with CVD and obesity had increased obesity-related cancer risk (body mass index: hazard ratio, 1.67 [95% CI, 1.17-2.31]). No significant associations were found in men, even after excluding prostate cancer. This study suggests that obesity is linked to higher obesity-related cancer risk in women with incident CVD, independent of shared risk factors. Further research is needed to eliminate residual confounding, understand sex differences, and explore how CVD pathophysiologies and obesity together influence cancer risk.

Sections du résumé

BACKGROUND BACKGROUND
Cardiovascular disease (CVD) and cancer frequently co-occur due to shared risk factors such as obesity, which is linked to CVD and 14 cancer types. This study explores whether CVD pathophysiologies, combined with obesity, increase cancer risk, impacting clinical management.
METHODS AND RESULTS RESULTS
Data from the ARIC (Atherosclerosis Risk in Communities) study, spanning 28 years, were analyzed. The cohort included 5127 participants with incident CVD (myocardial infarction, stroke, heart failure, coronary heart disease), of whom 1511 developed a first primary cancer. Follow-up began at CVD diagnosis after Visit 1. Obesity was assessed using body mass index, waist circumference, and waist-to-hip ratio. Incidence rate differences between obesity groups were adjusted for age, sex, and center, whereas the obesity-cancer association was estimated using Fine-Gray regression adjusted for shared risk factors including smoking. Cancer incidence in obese individuals with CVD (body mass index: rate differences=226.6/100 000 person-years) was higher than in those with normal weight. Although obesity was not linked to overall cancer after adjusting for shared risk factors, it was nominally associated with obesity-related cancers. Specifically, women with CVD and obesity had increased obesity-related cancer risk (body mass index: hazard ratio, 1.67 [95% CI, 1.17-2.31]). No significant associations were found in men, even after excluding prostate cancer.
CONCLUSIONS CONCLUSIONS
This study suggests that obesity is linked to higher obesity-related cancer risk in women with incident CVD, independent of shared risk factors. Further research is needed to eliminate residual confounding, understand sex differences, and explore how CVD pathophysiologies and obesity together influence cancer risk.

Identifiants

pubmed: 39189606
doi: 10.1161/JAHA.124.034438
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e034438

Auteurs

Sarah Malik (S)

Medical College of Georgia at Augusta University Augusta GA USA.

Avirup Guha (A)

Medical College of Georgia at Augusta University Augusta GA USA.

Xiaoling Wang (X)

Medical College of Georgia at Augusta University Augusta GA USA.

Neal L Weintraub (NL)

Medical College of Georgia at Augusta University Augusta GA USA.

Ryan Harris (R)

Medical College of Georgia at Augusta University Augusta GA USA.

Biplab Datta (B)

Medical College of Georgia at Augusta University Augusta GA USA.

Justin Moore (J)

Medical College of Georgia at Augusta University Augusta GA USA.

Priyanshu Nain (P)

Medical College of Georgia at Augusta University Augusta GA USA.

Sagar A Patel (SA)

Emory University Atlanta GA USA.

Steven Coughlin (S)

Medical College of Georgia at Augusta University Augusta GA USA.

Elizabeth Polter (E)

University of Minnesota Minneapolis MN USA.

Anna Prizment (A)

University of Minnesota Minneapolis MN USA.

Anne Blaes (A)

University of Minnesota Minneapolis MN USA.

Roberta Florido (R)

University of Utah Salt Lake City UT USA.

Shelby Kutty (S)

Department of Medicine Johns Hopkins University Baltimore MD USA.

Alvaro Alonso (A)

Emory University Atlanta GA USA.

Corinne E Joshu (CE)

Bloomberg School of Public Health Johns Hopkins University Baltimore MD USA.

Elizabeth A Platz (EA)

Bloomberg School of Public Health Johns Hopkins University Baltimore MD USA.

Classifications MeSH